Congratulations to Dr. Holly Hagan, professors of social and behavioral sciences with New York University College of Global Public Health and co-director of the Center for Drug Use and HIV/HCV Research, who has been invited to serve on the National Academy of Medicine Committee on the Examination of the Integration of Opioid and Infectious Disease Prevention Efforts in Select Programs. This is the second time she’s been invited to share her knowledge and help shape policy and research on this topic.
Trained as an infectious disease epidemiologist, Dr. Hagan is an expert in the epidemiology, prevention, natural history and treatment of hepatitis C virus (HCV) infection in people who use drugs. She served on the Institute of Medicine Committee on the Prevention and Control of Viral Hepatitis in the United States, and has been an advisor to the U.S. Department of Health and Human Services, the Center for Disease Control and Prevention (CDC), and the Canadian Institutes of Health on national programs to detect, diagnose and treat HCV infections. She currently chairs the National Institutes of Health (NIH)-CDC Rural Opioid Initiative, and is pursuing research questions related to the opioid epidemic in New York State.Tags: Friday Letter Submission